Patent application number | Description | Published |
20100137583 | Peptidomimetic protease inhibitors - The present invention relates to peptidomimetic compounds useful as protease inhibitors, particularly as serine protease inhibitors and more particularly as hepatitis C NS3 protease inhibitors; intermediates thereto; their preparation including novel steroselective processes to intermediates. The invention is also directed to pharmaceutical compositions and to methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an HCV infection or physiological condition related to the infection. Also provided are pharmaceutical combinations comprising, in addition to one or more HCV serine protease inhibitors, one or more interferons exhibiting anti-HCV activity and/or one or more compounds having anti HCV activity and a pharmaceutically acceptable carrier, and methods for treating or preventing a HCV infection in a patient using the compositions. The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient. | 06-03-2010 |
20120064034 | Peptidomimetic protease inhibitors - The present invention relates to peptidomimetic compounds useful as protease inhibitors, particularly as serine protease inhibitors and more particularly as hepatitis C NS3 protease inhibitors; intermediates thereto; their preparation including novel steroselective processes to intermediates. The invention is also directed to pharmaceutical compositions and to methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an HCV infection or physiological condition related to the infection. Also provided are pharmaceutical combinations comprising, in addition to one or more HCV serine protease inhibitors, one or more interferons exhibiting anti-HCV activity and/or one or more compounds having anti HCV activity and a pharmaceutically acceptable carrier, and methods for treating or preventing a HCV infection in a patient using the compositions. The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient. | 03-15-2012 |
20120282219 | PEPTIDOMIMETIC PROTEASE INHIBITORS - The present invention relates to peptidomimetic compounds useful as protease inhibitors, particularly as serine protease inhibitors and more particularly as hepatitis C NS3 protease inhibitors; intermediates thereto; their preparation including novel stereoselective processes to intermediates. The invention is also directed to pharmaceutical compositions and to methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an HCV infection or physiological condition related to the infection. Also provided are pharmaceutical combinations comprising, in addition to one or more HCV serine protease inhibitors, one or more interferons exhibiting anti-HCV activity and/or one or more compounds having anti HCV activity and a pharmaceutically acceptable carrier, and methods for treating or preventing a HCV infection in a patient using the compositions. The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient. | 11-08-2012 |
20140294763 | PEPTIDOMIMETIC PROTEASE INHIBITORS - The present invention relates to peptidomimetic compounds useful as protease inhibitors, particularly as serine protease inhibitors and more particularly as hepatitis C NS3 protease inhibitors; intermediates thereto; their preparation including novel steroselective processes to intermediates. The invention is also directed to pharmaceutical compositions and to methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an HCV infection or physiological condition related to the infection. Also provided are pharmaceutical combinations comprising, in addition to one or more HCV serine protease inhibitors, one or more interferons exhibiting anti-HCV activity and/or one or more compounds having anti HCV activity and a pharmaceutically acceptable carrier, and methods for treating or preventing a HCV infection in a patient using the compositions. The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient. | 10-02-2014 |
Patent application number | Description | Published |
20090021788 | Printer Systems and Methods for Global Tracking of Products in Supply Chains, Authentication of Products, and Connecting with Customers Both Before, During, and After a Product Sale - Printer systems and methods provide a plurality of unique identification codes to assignment devices in various geographical locations in order to assign a unique code to a single item of commerce through affixing tags or the like thereon or by direct printing. Information regarding which code is associated with which item of commerce may be captured and stored in database(s) along with other advertising, authenticity, distribution, manufacturing, note, quality control, and retail information. Inquires may be made regarding the codes by users with handheld devices including cellular phones, PDAs, notebook computers, barcode scanners, RFID readers, etc. through carrier networks, LANs, and WANs in order to obtain information about the item of commerce or related products. Stored information from the database may be provided to the users in response to their inquiries. Information may also be uploaded by the handheld devices for counterfeiting, diversion, and other tracking purposes. | 01-22-2009 |
20090114712 | Method of processing a ticket order - A method of processing a ticket order requesting the production of an identification tag for an article of commerce can be accomplished in the following manner. In the first step, a ticketing services provider receives the ticket order placed by the client, the ticket order including, inter alia, order information (e.g., purchase order information) with respect to the article to which the tag is to be affixed. Having received the order, the ticketing services provider associates a unique identification code, such as an automatically-retrievable electronic product code (EPC), with the identification tag (e.g., by programming the IC chip of an RFID tag with the unique identification code). In turn, a file is stored in an electronically-accessible database which links the unique identification code for the ID tag with the order information for the article to which the tag is to be affixed. In this manner, the client can retrieve the order information relating to each individual article of commerce that it produces. The ability to track order information for individual articles of commerce is useful in, among other things, anti-counterfeit, anti-diversion, inventory management and article return applications. | 05-07-2009 |
20090125416 | System and method of managing a ticket order - A system for managing the production of retail tickets in accordance with a ticket order includes a ticketing services bureau adapted to receive the ticket order and a print center to print tickets in accordance with the ticket order. The system additionally includes a client connected to the ticketing services bureau via an electronic network. As part of an interactive ticket proofing process, the client is capable of electronically retrieving an on-screen ticket proof from the ticketing services bureau and, if necessary, dynamically modifying the on-screen ticket proof in real time. The ticketing services bureau then generates an output data file based on the original ticket order, the edited on-screen ticket proof and print characteristics of the printer that will execute the ticket order. In this manner, the print center uses the output data file to generate tickets that closely resemble the on-screen ticket proof approved by the client. | 05-14-2009 |